Optimized SEEG-guided radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis

Xiaotong Fan, Yongzhi Shan, Chao Lu, Yang An, Yihe Wang, Jialin Du, Di Wang, Penghu Wei, Robert S. Fisher, Yuping Wang, Liankun Ren, Guoguang ZhaoSeizure 2019 · DOI

TL;DR

This paper introduces an optimized SEEG-guided radiofrequency thermocoagulation (RF-TC) technique for mesial temporal lobe epilepsy (MTLE) with hippocampal sclerosis (HS). By employing a novel three-dimensional cross-bonding of SEEG electrodes, they achieved larger, more effective lesions, leading to significant seizure reduction in 95.2% of patients and seizure freedom in 76.2% within 12 months, offering a promising minimally invasive alternative to traditional surgery.

What Problem Does This Paper Address?

Mesial temporal lobe epilepsy (MTLE) with hippocampal sclerosis (HS) is a common and often drug-resistant form of epilepsy. While traditional open surgeries like anterior temporal lobectomy (ATL) and selective amygdalohippocampectomy (SAH) are effective, they carry risks of cognitive impairment, visual field defects, and other complications. Minimally invasive techniques like MRI-guided laser interstitial thermal therapy (LiTT) have emerged, but their availability and widespread adoption are limited. Stereo-electro-encephalography (SEEG) guided RF-TC offers another minimally invasive option, but its efficacy for MTLE-HS has been historically lower than open surgery. This paper addresses the need for a more effective and accessible minimally invasive treatment for MTLE-HS by optimizing the SEEG-guided RF-TC technique to create larger, more impactful lesions.

Methods

The core innovation lies in the "optimized SEEG-guided RF-TC" procedure. Instead of standard SEEG-guided RF-TC, which typically involves lesioning between two contiguous contacts on a single electrode, this method utilizes a multi-electrode approach with "three-dimensional cross-bonding."

Here's a breakdown:

  • Targeted Electrode Placement: SEEG electrodes are implanted to precisely map the epileptogenic zone. A key electrode (OH) runs along the long axis of the amygdalohippocampal complex, while three orthogonal electrodes (TA, TH, TB) target specific parts of the hippocampus and amygdala. Additional electrodes can be placed to investigate potential extra-temporal foci.
  • Three-Dimensional Cross-Bonding: This is the novel aspect. Instead of just using contacts on a single electrode, the RF generator is connected to pairs of contacts from different electrodes simultaneously. This allows for a broader spread of radiofrequency energy, creating larger, confluent lesions. The authors explored one-dimensional (contiguous contacts on one electrode), two-dimensional (contacts on two electrodes in the same plane), and three-dimensional (contacts on multiple electrodes in different planes) cross-bonding.
  • Optimized Parameters: Based on in vitro experiments (on egg albumen and polyacrylamide gel) and in vivo rat studies, they determined optimal parameters. A key finding was that a lesion size of 5-7 mm could be achieved with contacts less than 7 mm apart, and a 60-second lesioning duration was found to be effective. In clinical practice, they used a power output of 3W for 10 seconds, followed by 50 seconds at that level, aiming for successful thermo-conduction and avoiding impedance collapse.
  • Procedure: After SEEG monitoring to identify the seizure onset zone (SOZ), bipolar coagulations were performed using the optimized cross-bonding technique within the SOZ. Electrodes were removed shortly after, and patients were discharged within 1-2 days.

Datasets

The study utilized data from 22 patients who underwent SEEG evaluation for medically refractory MTLE. Of these, 21 patients were ultimately included in the study for the optimized SEEG-guided RF-TC procedure. The data collected included clinical seizure semiology, scalp EEG, MRI, PET scans (for some), SEEG recordings, and post-operative follow-up data for up to 12 months. No new datasets were created or released.

Key Insights and Ideas

  • Expanding Lesion Size is Key: The central hypothesis that increasing the size of the RF-TC lesion would improve efficacy in MTLE-HS patients appears to be validated. The three-dimensional cross-bonding technique is the mechanism for achieving this larger lesion volume.
  • SEEG as a Therapeutic Platform: This work highlights SEEG not just as a diagnostic tool for localizing seizure foci but also as a platform for minimally invasive thermal ablation, integrating diagnosis and treatment into a single procedure.
  • Targeted Approach for MTLE-HS: The study emphasizes the importance of selecting patients with well-characterized unilateral MTLE-HS, suggesting that this specific subtype may be particularly amenable to this optimized RF-TC approach.
  • Safety and Tolerability: The procedure was well-tolerated with no reported neurological deficits or major complications, underscoring its safety profile compared to open surgery.

Key Results

  • High Seizure Reduction: At 12 months follow-up, 95.2% of the 21 patients experienced a >90% decrease in seizure frequency.
  • Significant Seizure Freedom: 76.2% of patients achieved Engel class I outcome (seizure-free or rare disabling seizures).
  • 38.1% were Engel class Ia (seizure-free).
  • 38.1% were Engel class Ib (rare disabling seizures).
  • Minimal Morbidity: No neurological deficits or major complications were observed during or after the procedure or during the 12-month follow-up. Transient prickling pain and occasional impedance collapse with hissing sounds were noted but were not considered major adverse events.
  • Lesion Visualization: Postoperative MRIs showed confluent lesions in the amygdala, hippocampus, subiculum, and entorhinal cortex, consistent with the targeted areas.

Limitations and Future Work

  • Small Sample Size and Uncontrolled Design: The authors acknowledge that this is a preliminary, observational study with a small sample size (n=21) and no control group. This limits the ability to draw definitive conclusions and compare directly with other treatments.
  • Lack of Formal Neuropsychological Testing: While no neurological deficits were observed, formal neuropsychological testing was not performed, which could provide a more detailed assessment of cognitive outcomes.
  • Potential for Bias: As with any observational study, there's a potential for selection bias and information bias (e.g., recall bias in seizure diaries), although the authors state they took steps to mitigate these.

Future Work: The authors are planning a randomized controlled trial (ClinicalTrials.gov ID NCT03941613) titled "SEEG Guided RF-TC versus ATL for mTLE With HS (STARTS)" to directly compare their optimized RF-TC technique with anterior temporal lobectomy. This will be crucial for establishing the comparative efficacy and safety of this novel approach.

Summary updated

BibTeX
@inproceedings{fan2019optimized,
  author = {Xiaotong Fan and Yongzhi Shan and Chao Lu and Yang An and Yihe Wang and Jialin Du and Di Wang and Penghu Wei and Robert S. Fisher and Yuping Wang and Liankun Ren and Guoguang Zhao},
  title = {{Optimized SEEG-guided radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis}},
  booktitle = {Seizure},
  year = {2019},
  doi = {10.1016/j.seizure.2019.08.011},
}
Figure